医学
曲妥珠单抗
肿瘤科
乳腺癌
单克隆抗体
内科学
化疗
癌症
佐剂
阶段(地层学)
辅助化疗
抗体
免疫学
生物
古生物学
作者
Martine Piccart,Marion Procter,Brian Leyland‐Jones,Aron Goldhirsch,Michael Untch,Ian Smith,Luca Gianni,José Baselga,Richard H. Bell,Christian Jackisch,David Cameron,Mitch Dowsett,Carlos H. Barrios,Günther Steger,Chiun‐Sheng Huang,Michael Andersson,Moshe Inbar,Mikhail Lichinitser,István Láng,Ulrike Nitz
摘要
Trastuzumab, a recombinant monoclonal antibody against HER2, has clinical activity in advanced breast cancer that overexpresses HER2. We investigated its efficacy and safety after excision of early-stage breast cancer and completion of chemotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI